IMPROVEMENT OF IMMUNOLOGICAL ABNORMALITIES ASSOCIATED WITH HYPERTHYROIDISM OF GRAVES-DISEASE DURING METHIMAZOLE TREATMENT

被引：0
|
作者：
MURAKAMI, M
KOIZUMI, Y
AIZAWA, T
YAMADA, T
ISHIHARA, M
HASEGAWA, Y
OGATA, H
KAMOI, K
KANEKO, K
机构：
[1] SHINSHU UNIV,SCH MED,DEPT GERONTOL ENDOCRINOL & METAB,MATSUMOTO,NAGANO 390,JAPAN
[2] NAGAOKA RED CROSS HOSP,DEPT MED,NAGAOKA,JAPAN
[3] SHINSHU UNIV,HOSP,CTR HEMATOL,SCH MED,MATSUMOTO,NAGANO 390,JAPAN
来源：
HORMONE AND METABOLIC RESEARCH | 1988年 / 20卷 / 04期
关键词：
D O I：
10.1055/s-2007-1010801
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：235 / 238
页数：4
相关论文
共 50 条
  • [31] INITIAL TREATMENT OF THYROTOXIC GRAVES-DISEASE WITH METHIMAZOLE - A RANDOMIZED TRIAL COMPARING DIFFERENT DOSAGES
    MESSINA, M
    MILANI, P
    GENTILE, L
    MONACO, A
    BROSSA, C
    PORTA, M
    CAMANNI, F
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (03) : 291 - 295
  • [32] IMPAIRMENT OF PREDNISOLONE DISPOSITION IN PATIENTS WITH GRAVES-DISEASE TAKING METHIMAZOLE
    LEGLER, UF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01): : 221 - 223
  • [33] Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease
    Nakamura, Hirotoshi
    Noh, Jaeduk Yoshimura
    Itoh, Koichi
    Fukata, Shuji
    Miyauchi, Akira
    Hamada, Noboru
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06): : 2157 - 2162
  • [34] PREDICTIVE FACTORS OF RECURRENT HYPERTHYROIDISM FOLLOWING RADIOACTIVE IODINE TREATMENT FOR GRAVES-DISEASE
    WU, P
    MCIVER, B
    THOMSON, K
    TOFT, A
    CLINICAL RESEARCH, 1994, 42 (02): : A267 - A267
  • [35] DIAGNOSIS AND SUCCESSFUL TREATMENT OF FETAL GOITROUS HYPERTHYROIDISM CAUSED BY MATERNAL GRAVES-DISEASE
    HATJIS, CG
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (05): : 837 - 839
  • [36] THYROID-FUNCTION AND IMMUNOLOGICAL ACTIVITY DURING AND AFTER MEDICAL-TREATMENT OF GRAVES-DISEASE
    GOSSAGE, AAR
    CRAWLEY, JCW
    COPPING, S
    HINGE, D
    HIMSWORTH, RL
    CLINICAL ENDOCRINOLOGY, 1983, 19 (01) : 87 - 96
  • [37] RESULTS OF DRUG-TREATMENT IN GRAVES-DISEASE AND NONIMMUNOGENIC HYPERTHYROIDISM (DISSEMINATED AUTONOMY)
    MENG, WE
    MENG, S
    HAMPEL, R
    VENTZ, M
    MANNCHEN, E
    KIRSCH, G
    THYROID 1988, 1988, 796 : 529 - 532
  • [38] HYPERTHYROIDISM - CAUSES, ETIOLOGY OF GRAVES-DISEASE, CLINICAL FEATURES, GENERAL ASPECTS OF TREATMENT
    GEFFNER, DL
    HERSHMAN, JM
    PHARMACOLOGY & THERAPEUTICS PART C-CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1976, 1 (3-4): : 401 - 422
  • [39] THE MANAGEMENT OF HYPERTHYROIDISM DUE TO GRAVES-DISEASE IN JAPAN IN 1988
    NAGAYAMA, Y
    IZUMI, M
    NAGATAKI, S
    ENDOCRINOLOGIA JAPONICA, 1989, 36 (02): : 299 - 314
  • [40] CONGENITAL HYPERTHYROIDISM, AFTER PREGNANCY COMPLICATED BY GRAVES-DISEASE
    MEDEN, H
    RATH, W
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1989, 49 (09) : 822 - 824
12345